Please use this identifier to cite or link to this item: http://ahro.austin.org.au/austinjspui/handle/1/11640
Title: Pilot alternating treatment design study of the splanchnic metabolic effects of two mean arterial pressure targets during cardiopulmonary bypass.
Authors: McNicol, Larry;Lipcsey, Miklos;Bellomo, Rinaldo;Parker, F;Poustie, Stephanie J;Liu, G;Kattula, A
Affiliation: Department of Anaesthesia, Austin Hospital, 145 Studley Road, Heidelberg, Melbourne, VIC 3084,Australia.
Issue Date: 2-Jan-2013
Citation: British Journal of Anaesthesia 2013; 110(5): 721-8
Abstract: The arterial pressure target for optimal splanchnic function during cardiopulmonary bypass (CPB) is uncertain. Thus, we aimed to compare the effects of two different arterial pressure targets during CPB on trans-splanchnic oxygenation, acid-base regulation, and splanchnic interleukin-6 (IL-6) and interleukin-10 (IL-10) flux.Sixteen patients undergoing cardiac surgery with CPB in a university affiliated hospital were subjected to a prospective alternating treatment design interventional study. We measured arterial and hepatic vein blood gases, electrolytes, IL-6, and IL-10 while targeting a mean arterial pressure (MAP) of between 60 and 65 mm Hg for 30 min, a MAP of between 80 and 85 mm Hg for 30 min (using norepinephrine infusion), and finally 60-65 mm Hg MAP target for 30 min.The MAP targets were achieved in all patients [65 (4), 84 (4), and 64 (3) mm Hg, respectively; P<0.001] with a greater dose of norepinephrine infusion during the higher MAP target (P<0.001). With longer time on CPB, hepatic vein O2 saturation decreased, while magnesium, lactate, glucose, IL-6, and IL-10 increased independent of MAP target. The decrease in hepatic vein saturation was greater as the temperature increased (re-warming). Overall, there was trans-splanchnic oxygen, chloride, lactate, and IL-6 removal during CPB (P<0.001) and carbon dioxide, bicarbonate, glucose, and IL-10 release (P<0.001). Such removal or release was not affected by the MAP target.Targeting of a higher MAP during CPB by means of norepinephrine infusion did not affect splanchnic oxygenation, splanchnic acid-base regulation, or splanchnic IL-6 or IL-10 fluxes. Australian and New Zealand Clinical Trial Registry ACTRN 12611001107910.
Internal ID Number: 23288353
URI: http://ahro.austin.org.au/austinjspui/handle/1/11640
DOI: 10.1093/bja/aes493
URL: http://www.ncbi.nlm.nih.gov/pubmed/23288353
Type: Journal Article
Subjects: Acid-Base Equilibrium.drug effects.physiology
Aged
Aged, 80 and over
Arterial Pressure.drug effects.physiology
Carbon Dioxide
Cardiac Surgical Procedures
Cardiopulmonary Bypass
Dose-Response Relationship, Drug
Female
Hepatic Veins.metabolism
Humans
Interleukin-10.blood
Interleukin-6.blood
Intraoperative Care.methods
Male
Middle Aged
Norepinephrine.administration & dosage.pharmacology
Oxygen.blood
Pilot Projects
Prospective Studies
Splanchnic Circulation.drug effects.physiology
Vasoconstrictor Agents.administration & dosage.pharmacology
Appears in Collections:Journal articles

Files in This Item:
There are no files associated with this item.


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.